Physician

George David Reeder, MD

According to 2025 Medicare claims, George Reeder, MD (NPI: 1760472153) practices pulmonary disease in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is TIDALHEALTH SPECIALTY CARE, LLC (NPI: 1619504735; TIN: 850529460) and primary practice location at 21801-5422.

Reeder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,499 traditional Medicare patients, billed 21,961 HCPCS/CPT codes, and received $740,108 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,593 prescription claims across 618 beneficiaries totaling $3,032,696 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 3,163 claims. Open Payments data shows 16 records totaling $474. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $150,351 to $740,108. Similarly, Part D prescription costs have moved sharply higher in recent years, from $359,081 to $3,032,696. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $81,841 to $236,184.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$406K$812K2015 Medicare payment: $150,351 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $206,873 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $383,293 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $486,283 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $649,628 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $735,837 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $678,302 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $811,560 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $738,427 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $740,108 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158383,397$150,351
20161,0516,250$206,873
20171,26212,968$383,293
20181,22115,885$486,283
20191,19920,460$649,628
20201,30520,190$735,837
20211,52717,476$678,302
20221,51819,714$811,560
20231,47318,523$738,427
20241,49921,961$740,108

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2015 Drug cost: $359,081 (USD; Tot_Drug_Cst)2016 Drug cost: $558,311 (USD; Tot_Drug_Cst)2017 Drug cost: $976,531 (USD; Tot_Drug_Cst)2018 Drug cost: $945,524 (USD; Tot_Drug_Cst)2019 Drug cost: $1,060,023 (USD; Tot_Drug_Cst)2020 Drug cost: $1,335,923 (USD; Tot_Drug_Cst)2021 Drug cost: $1,876,563 (USD; Tot_Drug_Cst)2022 Drug cost: $2,275,875 (USD; Tot_Drug_Cst)2023 Drug cost: $2,719,357 (USD; Tot_Drug_Cst)2024 Drug cost: $3,032,696 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015142716$359,081
20162641,290$558,311
20173792,093$976,531
20183601,991$945,524
20193831,910$1,060,023
20204862,375$1,335,923
20215262,804$1,876,563
20225623,214$2,275,875
20236113,693$2,719,357
20246183,593$3,032,696

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$193K$386K2015 Medicare payment: $87,694 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $72,053 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $127,186 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $160,118 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $168,804 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $222,497 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $236,380 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $289,998 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $386,036 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $317,432 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20152831,315$87,694
20164851,802$72,053
20179893,233$127,186
20181,1404,109$160,118
20191,1203,431$168,804
20201,2713,844$222,497
20211,1643,684$236,380
20221,0773,270$289,998
20231,0473,647$386,036
20247703,163$317,432

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more314386$92
94375Test to measure rate of airflow539594$10
94726Test to determine lung volumes using sensors698715$9
94060Test to measure expiratory airflow and volume changes before and after medication administration388390$7
94729Test to examine how well the lungs exchange gases706724$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OfevNintedanib Esylate641,920$860,751
Trelegy ElliptaFluticasone/Umeclidin/Vilanter64835,340$733,028
Dupixent PenDupilumab722,030$294,783
Breo ElliptaFluticasone/Vilanterol20713,080$164,999
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr1329,120$136,873

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramN1189$67,401
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R64$54,780
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY75610$53,151
E0483High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, eachYN/R55$48,344
A7031Face mask interface, replacement for full face mask, eachN43114$11,947

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$474GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for George David Reeder, MD?

Tedicare shows public-source Medicare data for George David Reeder, MD (NPI 1760472153), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George David Reeder, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George David Reeder, MD?

George David Reeder, MD is linked to TIDALHEALTH SPECIALTY CARE, LLC (billing NPI 1619504735) in the available physician profile data.

Does George David Reeder, MD have Open Payments data?

George David Reeder, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.